Nutex Health Inc. Common Stock earnings per share and revenue
On 19 nov. 2025, NUTX reported earnings of 7.76 USD per share (EPS) for Q3 25, beating the estimate of 1.11 USD, resulting in a 597.97% surprise. Revenue reached 267.80 million, compared to an expected 218.09 million, with a 22.80% difference. The market reacted with a +26.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analystes forecast an EPS of 6.97 USD, with revenue projected to reach 263.99 million USD, implying an baisse of -10.18% EPS, and baisse of -1.42% in Revenue from the last quarter.
FAQ
What were Nutex Health Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Nutex Health Inc. Common Stock reported EPS of $7.76, beating estimates by 597.97%, and revenue of $267.80M, 22.8% above expectations.
How did the market react to Nutex Health Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 26.87%, changed from $112.19 before the earnings release to $142.34 the day after.
When is Nutex Health Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 mars 2026.
What are the forecasts for Nutex Health Inc. Common Stock's next earnings report?
Based on 5
analystes, Nutex Health Inc. Common Stock is expected to report EPS of $6.97 and revenue of $263.99M for Q4 2025.